Detalhe da pesquisa
1.
Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.
Biotechnol Bioeng
; 112(6): 1102-10, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25689082
2.
Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses.
Nanomedicine
; 11(5): 1097-107, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25752855
3.
Therapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12.
Hum Vaccin Immunother
; 12(2): 421-30, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308597
4.
Allogeneic tumor cell vaccines: the promise and limitations in clinical trials.
Hum Vaccin Immunother
; 10(1): 52-63, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24064957